Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest China Health Resource Inc. Stories

2012-10-11 07:28:41

SICHUAN, China, Oct. 11, 2012 /PRNewswire/ -- China Health Resource, Inc. (OTCBB: CHRI) announced today it has extended its strategic agreement with the prestigious Chengdu University of Traditional Chinese Medicine. "Our ability to provide pharmaceutical grade herbs and proprietary products from our certified GAP ingredients allows us to earn higher profit margins and protect our franchise. This cooperation with the prestigious Chengdu University of TCM in addition to our...

2012-07-19 02:25:37

SICHUAN, China, July 19, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), today announced is expanding the company's Go Global Initiative to include the Migraine market and has appointed a task force to be headed by Ms. Cynthia Bitting to undertake USA strategic alliances under the Go Global Initiative. "Response to our newly developed Toufeng Migraine tablet has been overwhelming; we decided our Go Global Initiative platform must immediately be expanded to include...

2012-07-17 02:26:45

SICHUAN, China, July 17, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI) announced today the successful development of a revolutionary TCM migraine medication called Toufeng Migraine tablet. The medication has demonstrated an effective rate of 96.5% in clinical observations. The new product was developed utilizing the company's Dahurian Angelica (DAR) as one it's key ingredients. According to the company's forecast, the world's major pharmaceutical...

2012-06-19 02:27:26

SICHUAN, China, June 19, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI.OB News), announced today that it has signed a new sales letter of intent (LOI) for this year for its proprietary Yishen Capsule valued at 25 million RMB; approximately $4 million USD. The LOI was signed with Pengxi Huitong Pharmaceutical Ltd. for the purchase of a total of 2,200,000 packs for delivery thru 2012. YiShen Capsules are a proprietary product of CHRI used to treat fatigue by improving...

2012-06-05 02:28:48

SUINING, China, June 5, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), today announced it has issued a final termsheet to Herborium Group (OTC Pinksheets: HBRM) and is now awaiting response from the Herborium Board of Directors. Steve Weiss, USA Director of Strategic Acquisitions and Financial Marketing stated, "I am most excited to have united and introduced both CHRI with HBRM and my hope is for a favorable outcome. As CHRI revenues continue to significantly break all...

2012-05-29 02:26:19

SICHUAN, China, May 29, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), today announced results of earnings for the year ended December 31, 2011 and the first quarter of 2012. Revenues for the year ended December 31, 2011 were US $34,338,974, an increase of 234% over revenues of US $10,282,207 for 2010. For 2011 net income was $6,971,460, or $0.04 per fully diluted common share, compared with a net income of $2,707,286, or $0.02 per...

2012-03-12 06:00:00

TEANECK, N.J., March 12, 2012 /PRNewswire/-- Herborium Group, Inc. (HBRM.PK), www.herborium.com, is pleased to announce that the Phase 1 of due diligence for the sale of up to 100% interest to China Health Resources Inc (OTCBB:CHRI) has been completed. "We are very pleased with a timely progress of a due diligence and the completion of the First Phase of the process that is the exchange of the confidential information and documentation," stated Dr. Agnes P. Olszewski CEO of Herborium Group....

2012-03-02 06:00:00

TEANECK, N.J., March 2, 2012 /PRNewswire/ -- Herborium Group, Inc. (HBRM.PK) www.herborium.com is pleased to announce that the process of Phase 1 due diligence for the sale of up to 100% interest to China Health Resources Inc (OTCBB:CHRI) is underway. "We are very excited to advise that the process has begun and is moving along smoothly," stated Dr. Agnes P. Olszewski CEO of Herborium Group "As we have stated in our Press Release of 02/24/2012 regarding a signed Letter of...

2012-02-24 06:00:00

TEANECK, N.J., Feb. 24, 2012 /PRNewswire/ -- Herborium Group, Inc., (Pink Sheets: HBRM) www.herborium.com, a Botanical Therapeutics® company, announce today signing the Letter of Intent with China Health Resource, Inc (OTCBB.CHRI) for sales of up 100% interest in Herborium. Dr. Agnes Olszewski, Chairman and CEO of Herborium stated: "We are most excited to confirm that we are negotiating with China Health Resource, Inc. for an acquisition of up to 100% interests in Herborium....

2012-02-21 06:17:00

PRINCETON, NJ., Feb. 21, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI News), today has issued a letter of intent to acquire up to 100% of New Jersey based Herborium Group Inc (OTC PINKSHEETS: HBRM), a Botanical Therapeutics(®) company quoted under the symbol HBRM. "This action is a result of careful analysis of the strategy to capitalize on the need for urgent solutions in healthcare in the USA, China and globally. With healthcare costs rising and pervasive...